Pirfenidone Capsule
Product Images NDC 60219-1642

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Pirfenidone (NDC 60219-1642). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 (Pirfenidone Capsule 1)

Chemical structure diagram of Pirfenidone, showing the molecular framework including a methyl group, a pyridone ring, and a phenyl substituent attached to the nitrogen atom.*

FDA Label Image

10 (Pirfenidone Capsule 2)

A line graph comparing the percentage of patients experiencing changes in %FVC from baseline to week 52 between Pirfenidone and placebo groups. The x-axis shows absolute change in %FVC, ranging from -30% to 10%, while the y-axis shows the percentage of patients from 0% to 100%. The Pirfenidone group (n=278) is represented by a solid line, and the placebo group (n=277) by a dotted line, with annotations indicating specific patient percentages at -10% and 0% change points.*

FDA Label Image

10 (Pirfenidone Capsule 3)

A line graph showing the mean change in FVC (mL) over 52 weeks, comparing Pirfenidone (solid line) with placebo (dashed line). The graph illustrates the decline in FVC measurements at weeks 0, 13, 26, 39, and 52 for both groups, with Pirfenidone showing a less steep decline than placebo.*

FDA Label Image

10 (Pirfenidone Capsule 4)

A Kaplan-Meier survival curve comparing the percentage of patients alive over time in weeks for Pirfenidone versus placebo groups. The chart shows two lines representing survival rates for Pirfenidone (n=623) and placebo (n=624), with data on patients at risk at various time points and a hazard ratio with confidence interval noted on the graph.*

FDA Label Image

10 (Pirfenidone Capsule 5)

Label for Pirfenidone Capsules 267 mg by Amneal Pharmaceuticals NY LLC. The label includes dosage strength, an image of a white capsule with imprint, NDC 60219-1642-7, and storage instructions. Manufactured by Amneal Pharmaceuticals Pvt. Ltd., India, and distributed by Amneal Pharmaceuticals LLC, New Jersey. Package contains 270 capsules marked Rx only.*

FDA Label Image

10 (Pirfenidone Capsule 6)

Packaging label for Pirfenidone 267 mg oral capsules by Amneal Pharmaceuticals NY LLC. The label includes the proprietary name, strength, dosage form, NDC number 60219-1642, and storage instructions, indicating 270 capsules per bottle. The manufacturer is Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad, India, and distribution is by Amneal Pharmaceuticals LLC, Bridgewater, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.